Monocyte chemoattractant protein-1 gene delivery enhances antitumor effects of herpes simplex virus thymidine kinase/ganciclovir system in a model of colon cancer
- 14 October 2005
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 13 (4) , 357-366
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Enhanced antitumor effects of a bicistronic adenovirus vector expressing both herpes simplex virus thymidine kinase and monocyte chemoattractant protein-1 against hepatocellular carcinomaCancer Gene Therapy, 2003
- Enhanced anti-tumor effects of herpes simplex virus thymidine kinase/ganciclovir system by codelivering monocyte chemoattractant protein-1 in hepatocellular carcinomaCancer Gene Therapy, 2001
- Recombinant interferon α2a synergistically enhances ganciclovir-mediated tumor cell killing in the herpes simplex virus thymidine kinase systemCancer Gene Therapy, 1999
- Enhanced and Specific Gene Expression via Tissue-Specific Production of Cre Recombinase Using Adenovirus VectorBiochemical and Biophysical Research Communications, 1998
- Expression of costimulatory molecules B7-1 (CD80) and B7-2 (CD86) on human hepatocellular carcinomaHepatology, 1997
- Bystander Tumoricidal Effect in the Treatment of Experimental Brain TumorsNeurosurgery, 1994
- The B7 and CD28 receptor familiesImmunology Today, 1994
- The Role of the CD28 Receptor During T Cell Responses to AntigenAnnual Review of Immunology, 1993
- Tumor Rejection After Direct Costimulation of CD8 + T Cells by B7-Transfected Melanoma CellsScience, 1993
- Fixation, processing, and immunochemical reagent effects on preservation of T-lymphocyte surface membrane antigens in paraffin-embedded tissue.Journal of Histochemistry & Cytochemistry, 1987